1. Home
  2. Medical News
  3. Health Technology
advertisement

Epredia–Mindpeak EU Distribution Deal Expands Technology Access

epredia mindpeak eu distribution deal expands access to ce marked ai modules

03/09/2026

Epredia and Mindpeak announced a distribution agreement to bring Mindpeak’s AI-based image recognition software to Epredia’s digital pathology customers in the European Union.

Epredia will offer Mindpeak’s AI software for clinical diagnostics, translational research, and pharmaceutical development. Epredia described the distribution arrangement within an “end-to-end” pathology workflow and portfolio spanning consumables, instruments, and digital pathology systems, with AI-enabled tools included.

Mindpeak’s product description in the announcement highlights a portfolio that includes CE-marked modules alongside research-use-only modules. The press release describes the technology as delivering instant, pixel-level analysis of digital images of tissue samples and lists application areas including breast cancer, lung cancer, gastrointestinal pathology, biomarker quantification, and exploratory research studies. It also states the tools are designed to enable objective and reproducible assessments, with the software operable without requiring cloud connectivity for clinical and research environments.

The release also states that Epredia intends to explore future integration of Mindpeak’s AI solutions into the Epredia E1000 Dx Digital Pathology Solution workflow. This exploration would aim for a seamless workflow and streamlined data exchange through Epredia’s image management system between the scanner and Mindpeak’s modules. The announcement describes the E1000 Dx as a high-speed, automated whole-slide imaging scanner paired with a medical-grade viewer and image management and viewer software, and it notes a stated capacity to review up to 1,500 high-resolution digital images daily.

Key Takeaways:

  • The press release reports a distribution arrangement in which Mindpeak’s AI software will be offered via Epredia’s digital pathology customer channel in the European Union.
  • Mindpeak’s portfolio is described as including CE-marked clinical modules and as providing instant, pixel-level analysis that can run without cloud connectivity.
  • Epredia said it intends to explore future integration of Mindpeak AI into the E1000 Dx digital pathology workflow, including streamlined data exchange via its image management system.

NEW FEATURES:

Register

We're glad to see you're enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free